Ketamine is in the process of exploding out into one of the most popular pharmaceutical drugs, but the ketamine industry is not like the rest of the pharma world. As a gray market it operates outside of specific regulation, and as such, there are a few ketamine safety issues to be aware of, and ways to avoid them for a safe experience.
Ketamine safety issues are something to be aware of when getting into ketamine treatment. This should not dissuade those looking for better treatment options, however. We are an independent publication reporting on the expanding cannabis and psychedelics fields of today. Play along by subscribing to The Cannadelics Weekly Newsletter, and receive your daily dose of industry news, while being first in line for new product promotions.
Why are we talking about ketamine?
This is a great question, and the answer creates a complicated framework, for which new and unexpected problems have arisen. Ketamine is a synthetically-made dissociative hallucinogen, not to be confused with ‘psychedelics’ which are simply a different genus within the classing of hallucinogens. Dissociative hallucinogens, which also include PCP and DXM, can often be used as anesthetics, and the high they produce is akin to being under anesthesia. In fact, take too much ketamine and you’ll k-hole yourself, essentially putting yourself under anesthesia.
The reason the aspect of anesthesia is important, is because anesthetics keep people from feeling pain, which means by nature, ketamine is associated with pain control. The reason the aspect of a hallucinogen is important, is because much like other hallucinogens (MDMA, psilocybin…), ketamine has shown the ability to change the way a person thinks, essentially allowing for new thought processes to be made, which is incredibly important for dealing with psychological issues. This has been exemplified in a study with eating disorder patients, whereby the thought is that ketamine actively blocked the circular thinking behavior related to excitement of the hippocampus by glutamate-NMDA receptors leading to strengthened thinking patterns. After ketamine treatment, the majority of patients decreased or ceased their compulsive thoughts.
As such, ketamine works on two fronts, providing a measure for depression, postpartum depression, eating disorders and other similar issues, as well as a way to control pain issues. Whereas monoamine antidepressants repeatedly fall short, ketamine seems to give better results, and whereas opioids cause mass addiction and overdose issues, ketamine is not related to either of these things. Both official research, and the existence and proliferation of the ketamine industry, both point to ketamine providing a better answer to these two issues.
The thing is, ketamine was never approved for these things. It’s half-brother esketamine was legalized only for treatment-resistant depression, but ketamine remains officially approved as just an anesthetic. The way it exists in the growing number of clinics providing ketamine treatment, is as an off-label medication, legally prescribed by a doctor for uses not officially approved by the FDA. This ability for off-label prescribing is the basis for the ketamine loophole, and the existence of this growing ketamine industry.
Is ketamine safe?
There are different ways to measure safety, and different concerns that can cause safety issues. One of the best measures is in death and injury. For all the government does to ignore it, ketamine has no real death toll. This isn’t to say that there has never been a problem, but these problems are so few and far between, that they don’t really register. Go ahead…do a search for ketamine death numbers. You won’t find any. In fact, the most you’ll find, are numbers of deaths where ketamine was involved, but the problem here, is that these are cases where other things were also involved, like opioids, or cocaine.
Even if you buy into the fear of it, you’re still going to have a difficult time finding those overdose death numbers. But where you won’t have that problem, is with opioids, the main medications used to treat pain issues. In fact, the numbers are so grossly huge, we now call it an ‘opioid epidemic’. Recent CDC numbers approximated 2021 overdoses at over 100,000, and this insanely large number owes most of its growth to the ballooning opioids industry. In 2020, for example, out of around 93,000 overdose deaths, nearly 70,000 were from opioids.
So is ketamine safe? Yes, especially in comparison to any of the drugs that make up that overdose list, because ketamine isn’t one of them. But it’s also not a drug pushed by the companies in the ‘Big Pharma’ grouping, which make up the largest and most powerful pharmaceutical companies, and the ones that pay out big bucks to government representatives.
Ketamine can be made by any pharma company, and in plenty of random basements, and this means Big Pharma companies don’t make money off it, and therefore aren’t going to put money in representatives’ pockets for it. Where do they make their money? Opioids. How nice for them that these drugs are so addictive, and that the government is so partial to anyone willing to pay out.
So, who has died from ketamine?
While some publications like to spout the oft said line that we don’t have much information on long-term use, or that we don’t know about certain effects, these lines are completely untrue. In terms of pain, it was established in the 1960’s during prisoner studies, that ketamine was especially good for pain, so much so that it was consequently used for soldiers in the Vietnam war. It’s also been a big player in the recreational game since the 1980’s, so there is plenty that can be gathered from users going back to that time. If nothing much is said about damage from long term use, its likely because there’s nothing to report on. When looking at opioids, cocaine, or methamphetamine, for example, health issues from long-term use are easily found.
This is all exemplified by China, where there are plenty of articles shouting about a ketamine issue, but a reality of literally no direct death count, with the very few deaths (out of over a billion, let’s remember) also being associated with other drugs. It sounds like ketamine has grown in popularity in China, but anyone clamoring on about it causing mass safety issues, isn’t looking at the facts. There are a couple other things written about bladder issues with extreme use, but not only is extreme use of anything generally related to something uncomfortable, but the existence of this complaint is so sparse, and the examples so few, that it starts to sound more like a smear campaign than anything else.
This study from Australia is also harping on ketamine as unsafe, but when looking more closely, this is nothing but a farce. 95% of deaths spoken of, involved other drugs, nearly 60% of which were opioids. Hypnosedatives were in the blood of 57.6%, psychostimulants were also used by 50.0%, and alcohol was present for 27.3%. Almost 29% had regular antidepressants in their system as well. Also worth mentioning, over 82% had pulmonary edema, and almost 27% had pneumonia. So it’s not really about ketamine in the end, and the idea that the title of the study is headlined Characteristics and circumstances of death related to the self-administration of ketamine, is a joke at best.
Ketamine safety issues
So, sure, ketamine is technically safe. But it doesn’t mean that ketamine doesn’t have safety issues to consider, especially considering the industry itself. And it’s the tactics of the industry, where prospective users should be careful.
- One of the biggest ketamine safety issues is that as a growing industry, everyone wants to get in on it. As a medical provider, any clinic that wants to prescribe and dispense it, must follow certain medical protocols. However, as ketamine itself isn’t regulated for these uses, there are no specific protocols that must be followed in how its dispensed and used. This opens the door for misuse and confusion, as well as sub-par products.
- For example, some clinics don’t require the patient to be in the clinic, and will actually send the medicine to the home of the patient, or prescribe it for them to pick up at a pharmacy. In these cases, no doctor is present when the medication is taken. Some do a session via a video call, or require a babysitter to be there, but the latter can’t be guaranteed, and there isn’t necessarily a way to protect a patient from unsafe surroundings. Allowing a person to go into such an uncontrolled state, without assuring their safety, is incredibly dangerous. Ketamine, it should be remembered, is one of the drugs often used for date rape.
- The other issue with sending someone home with the medicine, rather than administering it in a medical setting, is that it means its not going to be used by injection, but rather by oral ingestion. As oral ingestion provides for much lower and inconsistent bioavailability (the ability of the body to actually absorb and use it), dosing is much less precise, and is generally given in much larger amounts to account for the lessened bioavailability. This means users and their prescribing doctors have no idea how strong the dose will actually end up being, and this could be the difference between a light dose, and giving way too much.
How to avoid ketamine safety issues
The best way to avoid these issues, is to only use a service that requires in-patient treatment. In-patient treatment means that the ketamine is given via IV injection, so the dose is much more refined for the specific patient, and there is less of an issue with giving too much. Plus, as it doesn’t require going through the body, it means that dosing is consistent across treatments, without worrying about other factors changing how much gets absorbed.
Going to in-patient treatment facilities also gets rid of the fear of danger when being put in a state of lessened response. If a person is made high to the point of a k-hole, they cannot control what happens to them, or who could hurt them. Even though many people take the oral dosage in their home, this doesn’t always rule out danger. Being in a medical setting gives an extra layer of protection to ensure that nothing bad happens to a patient when under the influence. As with any drug, there can be adverse effects, or unexpected circumstances. Being in a medical setting means having trained professionals right there that can assist.
While there are plenty of decent clinics to choose from, examples like Pasithea represent the highest level of care offered, the most adherence to safety policies, and a general lack of the behavior seen by unscrupulous companies that promote these safety issues. Prospective patients should do their homework and only use a clinic that values their personal safety.
As with any industry that has a seedy side, it’s important for customers to know who they’re dealing with. Clinics that cut corners represent the shadier side of this industry, and show a greater level of apathy towards their clientele. Clinics that adhere to as many general safety practices as possible – even if they’re not technically required to, represent the higher end, and are the safer companies to work with.
These treatments can be expensive, so it’s no wonder that consumers often head toward a cheaper option. Hopefully costs will come down eventually, so that those who want this treatment, but can’t afford a better clinic, won’t be pushed to using unsafe practitioners. Ketamine holds a lot of value, but like anything else, it should be administered and used responsibly.
Ketamine might provide a safe answer for dealing with psychological disorders and pain, but it doesn’t mean that it doesn’t come without issues. There are plenty of ketamine safety issues to consider, but luckily, simply using the right provider can dispel the majority.
Hello, thanks for stopping by! Welcome to CBDtesters.co / Cannadelics.com, a #1 offering for wide-ranging news covering the cannabis and psychedelics fields. Join us whenever you can to stay current on all goings on, and subscribe to The Cannadelics Weekly Newsletter, for daily updates on everything important happening now.
Psyched Wellness is Bringing You Amanita Mushrooms – And It’s All Legal
Magic mushrooms are the new buzz word, but they don’t all fall into just one category. Sure, there are psilocybin magic mushrooms, but there are also amanita mushrooms, for a different kind of high and unique medical advantages. Now, the company Psyched Wellness is offering amanita mushroom products, and the best part is, it’s all legal.
We all know about psilocybin mushrooms, right? Well, now there’s a new mushroom to know about, Amanita muscaria, and these mushrooms are not only legal, but come with a host of medical benefits. If you’re into independent drug reporting concerning the cannabis and psychedelics fields, this is the publication for you. We provide the Cannadelics Weekly Newsletter so readers can stay updated on current events, as well as have access to tons of deals on cannabis products including popular cannabinoid compounds Delta 8 THC, and HHC, and all upcoming hallucinogenic products. Check the ‘best of’ lists for offers, and choose the products you’re most comfortable using.
What are amanita mushrooms?
When you hear the term ‘magic mushrooms’ the go-to association is with psilocybin mushrooms, the shrooms readily found in North and South America, which cause trips and highs by activating serotonin receptors. These mushrooms, along with LSD, DMT, and other compounds, are considered psychedelic hallucinogens.
This group of psychedelic hallucinogens doesn’t include other drugs we often think of as psychedelics, like ketamine. That drug, along with PCP and DXM are all dissociative hallucinogens. There is a third group as well, called deliriant hallucinogens, which includes scopolamine, the drug used to rob people by taking away their ability to argue with perpetrators. These three represent serotonergic, dopaminergic, and anticholinergic hallucinogens only.
This is where amanita mushrooms come in, as hallucinogens that act on a different neurotransmitter, GABA. Amanita muscaria mushrooms – AKA fly agaric, (for their ability to attract and trap flies), are also wild mushrooms that produce some trippy effects, but with an entirely different mode of action then psilocybin mushrooms. Amanita mushrooms are considered poisonous mushrooms, and contain a compound called muscimol, which is GABAergic. This means it acts as an agonist on GABA receptors, and does so in the same way as GABA itself; rather than attaching to different receptor sites like benzodiazepines, barbiturates, and Quaaludes.
These mushrooms also contain ibotenic acid, which is the compound more likely to make a person sick. This compound is a prodrug (a compound which is biologically inactive until metabolization), and is metabolized in the body to become muscimol. This is similar to psilocybin, which is also a prodrug, and which is useless in the human body until it changes into the other compound found in magic mushrooms, and the real compound of interest, psilocin.
Whereas psilocin acts on serotonin receptors, creating a stimulant response along with its psychedelic effects, muscimol acts on GABA receptors that calm the body down. Amanita mushrooms therefore won’t cause the same kind of ‘bad trip’ as psilocybin mushrooms, since there’s no stimulant effect. They do, however, come with their own reasons for caution in how they’re prepared and eaten, so as not to make a user feel sick. Neither mushroom group is known to cause death (despite the name ‘poisonous’), so even a bad experience with either is only temporary.
Amanita mushrooms are less well-known in the Americas as they’re not native to this region. For the most part they’re found around Northern Europe and Russia (particularly Siberia), and factor into medicinal and shamanistic traditions in those regions. This is probably why they aren’t scheduled in the US Controlled Substances list, which makes them legal to have and use in the US.
A little about Psyched Wellness & Calm
Psyched Wellness is a publicly traded company on the Canadian Securities Exchange under (CSE:PSYC), which used to be Duncan Park Holdings Corporation. Based out of Toronto, Psyched Wellness is a life sciences company which just finished a pilot run for its new amanita mushrooms product, Calm.
This main offering of the company, Calm, is the first approved amanita mushroom product to hit US markets. According to the company, its made 100% from amanita mushroom caps, is lab tested, detoxified to ensure no bad effects (no ibotenic acid), and can be used to “reduce stress, ease muscular tension, and promote restorative sleep.” The company is taking preorders for the product right now, and interested buyers can reserve themselves a 1 fluid ounce bottle for $49.99. Products are expected to officially hit the market in the fall.
Calm registers as a dietary supplement, which is advertised as ethically sourced. The main component, according to the company’s site, is AME-1 which was developed in the Psyched Wellness laboratories to mimic the naturally extracted compound muscimol. It does not contain naturally occurring muscimol. As this is not a controlled substance, and doesn’t require a prescription, the company is free to sell it without the same complications that currently exist with psilocybin mushrooms, which are still federally illegal as they sit in Schedule I of the controlled substances list.
The company is looking to expand its product offering in the future. According to CEO Jeffrey Stevens, “It has been a long journey to get to this point, and I would like to take this opportunity to thank my co-founder, David Shisel, our team, KGK Science and Vantage Hemp for all of their hard work and commitment to get us to where we are today. The most exciting part for me is that we have just scratched the surface with respect to potential uses and delivery forms for AME-1. Stay tuned for more to come from Psyched.”
Aside from this compound, the company also sells accompanying sweatshirts, bags, T-shirts, phone covers, water bottles, hats, and mugs, some emblazoned with the well-known image of the red capped mushroom with white spots. While Super Mario Brothers certainly kept this image alive for years, its new entrance into the US sales market is sure to give it an extra popularity boost in the near future.
A bit more on muscimol from amanita mushrooms
For many people, these mushrooms represent something completely new. Whereas psilocybin mushrooms have been used in the Americas for millennia, both for medical and recreational purposes, amanita mushrooms are not well-known to this part of the world. They are therefore a mystery to Americans in terms of what they can do, what to be wary of, and how they differ from standard magic mushrooms. In an interview with Technology Networks, Jeff Stevens gave some insight into these ‘other’ hallucinogenic mushrooms.
Of muscimol he says, “Muscimol is one of the main psychoactive compounds found in the Amanita muscaria mushroom along with ibotenic acid and muscarine. Although it does have psychoactive properties, the effect is very different from psilocybin or psilocin. It reacts with the GABAA receptor and when ingested, it can provide feelings of euphoria and tranquility, an altered sense of hearing and taste, changes to sensory perception and vivid dreams.”
He goes on to stipulate that “If it is not processed properly, where the ibotenic acid is not converted to muscimol, it can provide quite a nasty experience including sweating, nausea, loss of balance and involuntary bodily movements.” This helps explain how amanita mushrooms can cause negative effects, but don’t have to so long as the right usage techniques are employed.
In terms of why we’re only hearing about muscimol now, he says, “We believe the reason muscimol has not been studied to a large degree is because it has been mislabeled as poisonous and as such was overlooked. As a result, there’s not been a lot of scientific studies conducted on muscimol so groups like Psyched Wellness need to start from the ground up, making it more time consuming and more expensive.”
When it comes to the legality of the mushrooms, he explains, “Amanita muscaria are considered food and are principally regulated under the Federal Drug Act and the Consumer Packaging and Labelling Act in Canada and the Federal Food, Drug and Cosmetic Act and The Nutrition Labelling and Education Act in the USA. As a result, the challenges that other compounds face with extraction, regulation and or administration are not a factor.”
Psyched Wellness has been going over accumulated research on these mushrooms, looking for different applications. Says Stevens, “we believe muscimol could show positive indications for various mental and physical health issues, including sleep, insomnia, addiction and pain.”
Amanita mushrooms represent a different option in the world of hallucinogenic treatment. It’s not just about standard psychedelics anymore, and amanita mushrooms, with their main psychoactive constituent muscimol, offer an entirely different approach to helping with mental and physical health.
Hello and welcome! Thanks for making it to Cannadelics.com, a top platform for independent coverage of everything in the cannabis and psychedelics worlds. Read-thru the site daily for updates, and subscribe to the Cannadelics Weekly Newsletter, for news items and the best in product offerings.
Double Standards – Will Biden Keep His Cannabis Reform Promises?
Regardless of what side of the political fence you’re on, there is one thing everyone can agree on: Republicans are more conservative, and Democrats are more liberal – especially when it comes to progressive drug policies. And while this statement rings true almost 100% of the time, the exact opposite applies to our current president, Joe Biden.
While Biden has made many cannabis-related promises along the campaign trail and during his time in office, and he has supported a handful of modest reform proposals, the White House has made it very clear that his overall position on adult-use legalization has not changed over the years: he is NOT in favor. And this is despite overwhelming support for progressive policy change among voters in his party.
To stay current on everything important happening in the industry, subscribe to The Cannadelics Weekly Newsletter. Also, it’ll get you premium access to deals on cannabis flowers, vapes, edibles, and much more! We’ve also got standout offers on cannabinoids, like HHC-O, Delta 8, Delta 9 THC, Delta-10 THC, THCO, THCV, THCP & HHC, which won’t kill your bank account. Head over to our “Best-of” lists to get these deals, and remember to enjoy responsibly!
Biden’s daughter-in-law shops for weed with secret service detail
In the most recent Biden-cannabis drama, it was reported last month by the Daily Mail that Melissa Cohen, wife of Hunter Biden and the president’s daughter-in-law, was seen leaving a Malibu-based dispensary called 99 High Tide, and she was carrying a “small unidentified purchase”. Additionally, it was noted that following Cohen was a plain-clothed secret service agent.
Although cannabis is recreationally legal in California and many other states, it’s still federally prohibited… and that’s not exactly where the issue lies anyway. The real problem here, is the idea of using a federally funded secret service to protect one of Biden’s relatives during a pot transaction, while tens of thousands of people remain behind bars for past nonviolent possession charges.
In giving the benefit of the doubt, it’s plausible that Cohen was in the store buying one of their few high-CBD products – which are federally legal. However, while searching through their online menu, I found only one product that fit the bill; the rest of their “CBD products” contained various ratios of THC and CBD, all of which resulted in more than 0.3% THC, and thus, more than the federally legal limit. So, while there is a slight possibility that Cohen was buying CBD products at a recreational cannabis dispensary, it’s highly unlikely.
It’s also worth noting that the Daily Mail’s claim of Cohen having a secret service agent in tow could not be independently verified, as the White House would not respond to questions from the various news sources who have reached out for comments.
White house staffers fired for admitting to past cannabis use
Last spring it was reported through various news outlets that “dozens of young White House staffers, freshly hired were abruptly told to quit, were suspended from their jobs, or otherwise punished “due to past marijuana use.” This happened after the staffers personally admitted to having used cannabis in the past on security clearance application forms. It’s worth noting that cannabis has been legal for adults 21 and older in Washington D.C. since 2015.
The firings and suspensions fly in the face of the more progressive appearance that the White House is trying to present, and their new policies. In February (one month before this incident), the White House Office of Personnel Management stated that past cannabis use was no longer an automatic employment disqualifier, and that federal agencies “should exercise special care before making a determination of unsuitability” in such circumstances.
Whether the staffers’ cannabis use was recreational or medical, legal or illegal, was never made clear. Of the few staffers who commented, under anonymity, the general consensus was that it would not have mattered either way. “The policies were never explained, the threshold for what was excusable and what was inexcusable was never explained,” mentioned one former employee.
The reason why cannabis is considered a “national security risk” or a disqualifier for federal employment, also remains unclear. Both the FBI (Federal Bureau of Investigation) and NSA (National Security Agency) have recently updated their policies on past cannabis use, claiming that it was difficult to find hackers and cybersecurity experts with clean drug records.
Biden’s sketchy history with drug reform
He’s made improvements over the years, but as his documented history shows us, there were very few D.C. lawmakers who were tougher on drugs in the 1980s and 1990s than Senator Joe Biden from Delaware. During the entirety of those 2 decades, Biden was a prominent figure in the War on Drugs and was responsible for unjustly imprisoning tens of thousands of Americans – many of which were minority or low-income individuals – on trumped up drug charges, including thousands for cannabis.
Specifically, Biden introduced numerous bills with that would implement harsh penalties for those convicted of producing and distributing federally prohibited, or schedule 1, narcotics. These bills called for increased severity in dealing with first offenders, as well as longer prison sentences for all. One specific piece of legislature that comes to mind is the 1994 Violent Crime Control and Law Enforcement Act, which sounds good but unfortunately played a key role in mass incarcerations for drug offenses, even many who were not involved in violent crimes.
Biden’s stance never really changed, with him quoted making anti-cannabis comments as recently as 2010. “There’s a difference between sending someone to jail for a few ounces [of marijuana] and legalizing it,” Biden stated in an ABC News Interview. “The punishment should fit the crime. But I think legalization is a mistake. I still believe [marijuana] is a gateway drug.”
However, Biden claims that his views on marijuana have improved lately – but he can say whatever he wants, his actions, however, raise questions. Knowing that Americans want cannabis legalized and available to them, Biden completely changed his tune come January 2019. “There’s a difference between sending someone to jail for a few ounces [of marijuana] and legalizing it. The punishment should fit the crime. But I think legalization is a mistake. I still believe [marijuana] is a gateway drug,” Biden claimed.
A few months later, while speaking with New Hampshire voters in May 2019, Biden commented that, “Nobody should be in jail for smoking marijuana.” He laid out a ‘plan’ for decriminalizing marijuana, if elected, and automatically expunging existing criminal records for possession by reclassifying cannabis to a Schedule II substance (it is currently a Schedule I, reserved for drugs with the highest potential for abuse and addiction).
And in his last 2 years as president, he has acted on exactly zero of his cannabis-related promises. Cannabis is still not federally legal, or even decriminalized, people are still getting in trouble for it in prohibition states, and many are still serving prison time for old cannabis charges in states that have recently legalized. So again, his actions show much less support than he likes to claim.
In one of his latest moves, he suggested forced rehabilitation for anyone caught with drugs. According to President Biden, “nobody convicted of a drug crime should go to prison, they should go to mandatory rehabilitation,” he emphasized at a campaign event in Kenosha, Wisconsin late last year. “Instead of building more prisons… we [should] build rehabilitation centers.” And while I completely agree with the first half of the statement, the idea of putting a cannabis user in rehab, just sounds completely asinine. Although it seems that he’s trying (a little bit), at best, he’s just very out of touch with what modern day drug policy should look like, and what his voters are asking for.
And Vice President Kamala Harris is not much better, claiming to support legalization and even bragging about having smoked in the past, but her resume says otherwise. During her career as San Francisco district attorney, Harris oversaw roughly 1,900 marijuana convictions (1,500 of which were African American males, for the record). NORML executive director Erik Altieri describes her history on drug reform has been “problematic,” and her “record is not one anyone would qualify as progressive, particularly when it comes to marijuana.”
Biden pardons a few cannabis offenders
And when I say “a few”, I truly mean that. More specifically, he pardoned 3 people and commuted the sentences of 78 offenders, out of the estimated 40,000 people who remain locked up on weed charges. Before getting further into the details, let’s quickly go over the difference between pardons and commuted sentences A pardon completely removes the conviction as if it never happened, so the person’s record is clear, whereas a commuted sentence still stands but the punishment is reduced or completely revoked.
The news of the pardons and commuted sentences were announced on Tuesday, April 25th of this year. All of the pardoned offenders had been previously released to serve time in their homes during the pandemic, a privilege that was granted to a total of 8.300 inmates because of COVID-related issues and prison overcrowding. One of the pardons given, and eight of the commuted sentences, were related to cannabis.
Now, it’s important to note that this was not part of some cannabis-related project or anything special that Biden was doing. These pardons and commuted sentences were done in clemency grants as part of Biden’s first year in office – and this is standard for ALL presidents during their first year. Call it a presidential ‘get out of jail free’ card, if you will, but regardless, it had nothing to do with commuting the sentences of cannabis users specifically, even though some of the offenders who got pardoned and commuted were convicted of non-violent marijuana crimes.
New cannabis legalization bill from Chuck Schumer
The reason this matters (well, it always matters, but the reason it’s more relevant now) is because a new decriminalization bill was introduced by Democratic Senate Majority Leader Chuck Schumer and Thursday, July 21st. The bill isn’t exactly new, Schumer has been working on it for years, waiting for the right time to make it official.
The Cannabis Administration and Opportunity Act would effectively decriminalize cannabis at the federal level, but would allow individual states to regulate it as they see fit. So, some states can still choose to keep it illegal, although that seems unlikely. That said, it’s hard to say how likely it is that this bill will even pass at all. Yes, Schumer circulated the bill around for the last few months getting feedback for how to make it foolproof, but there are still a few major potential obstacles in the way.
First, we have the Senate. Although legalization/decriminalization bills have passed the House of Representatives, they have all died when reaching the Senate for a vote. Beyond the Senate, the main concern here is Biden. Should the bill make it his desk, will he off on it? He claims to support decriminalization (hopefully more so now that we all know his daughter-in-law shops at dispensaries), but his history, as well as his areas of focus while in office, say otherwise.
In all fairness, it’s not surprising to see an old man stuck in such dated ways. It’s reminiscent of many of our own grandparents who just won’t get with the times. But a politician should be more in touch with what the general population wants, and data from Politico consistently shows that roughly 70% of Americans want cannabis legalized. With this new bill in the works, it’s very possible that the ball will soon be in Biden’s court – and it will be interesting to see what he does with it.
Welcome all! Thanks for dropping by Cannadelics.com, a top offering for comprehensive news covering the burgeoning cannabis and psychedelics industries. Stop by daily for a dose of news on these dynamically changing fields, and sign up for The Cannadelics Weekly Newsletter, so you’re up on everything important going on.
Switzerland Implements Wide-Reaching Medical Cannabis Program
All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits.
Switzerland is on a rampage, both widening its medical cannabis program, and awaiting new recreational legislation. Cannadelics is an independent news source focusing on the cannabis and psychedelics fields of today. Remember to subscribe to The Cannadelics Weekly Newsletter all the latest news and industry stories, as well as exclusive deals on flowers, vapes, edibles, and other products. Also save big on Delta 8, Delta 9 THC, Delta-10 THC, THCO, THCV, THCP & HHC products by checking out our “Best-of” lists!
Switzerland up until now
Switzerland is all over the board these days, but up until recently, this was not the case. So what was the deal with Switzerland up until its impressive moves of late? First off, Switzerland is not a part of the EU, so it never had to go by EU regulation. Whereas products with up to .3% THC are legal in EU countries, Switzerland has a max THC level of 1%. Outside of this, cannabis is illegal.
In 2012, the country instituted a decriminalization measure which allowed for small amounts of cannabis (up to 10 grams) with only a 100 Swiss Franc fine, and no jail time included. Once either the 10-gram limit is gone over, or the 1% THC limit, a violator is subject to both a fine, and a prison sentence up to three years.
A lot happened in 2012, though it didn’t all stick. That year, certain cities gained the ability to legally grow low-THC hemp, up to the 1% limit. But then, Just months after this started, the government itself nullified this ability, because it said it was in violation of federal drug laws. Switzerland operates like many multi-state countries where cannabis penalties vary between its different states.
In another 2012 measure, legislation was instituted that made both selling cannabis, as well as possessing amounts enough to affect as many as three people, punishable by up to three years in jail, along with a possible fine. This was updated in 2017 to exclude possession, and to only fine those actively using; which allowed many states to drop possession cases for small amounts.
In terms of Switzerland and a medical cannabis program, the country didn’t have a comprehensive one until current events. The Federal Act on Narcotics and Psychotropic Substances in 2008 (implemented in 2011) allows Swiss doctors to get special permits to prescribe cannabis to terminal patients, for 12 months at a time. It also requires patients to apply for authorization from the FOPH (Federal Office of Public Health). Only tinctures and oils were approved by this measure, and its hardly wide-ranging, with only two pharmacies able to provide such medications.
This didn’t stop the pharma medicine Epidiolex from gaining approval in 2018, even as flowers and resin are both barred. From this time, however, pharmacies have been able to create specific CBD formulations for patients. Overall, the ability to access cannabis medicines has been highly restricted in Switzerland, though recent changes are now opening the country to much wider usage, with even bigger plans for the future.
Switzerland updates medical program
Everything just mentioned about Switzerland and its medical program, has now been updated thanks to a new amendment put forth by the country’s seven-member Federal Council, which is the country’s joint head of state and federal government. This amendment updates the Narcotics Act to erase the ban on medical cannabis, which in turn creates a much wider market.
Starting in the beginning of August, patients no longer have to apply for the authorization from the FOPH, and can now get a regular prescription, straight from their doctor. The new amendment isn’t just meant for patients in Switzerland, but predictably for an export market as well (very few legalizations of this sort don’t include the ability for an export market). Less was stated about an impending import market. The limit for THC is still the same for all products, at 1%.
Part of the reason for this change, was due to increasing demand for medical authorizations, which had grown to the point of burdening the government with extra administrative work, which led to treatment delays for patients in need. The conditions for treatment also expand under this new amendment, letting more people benefit from cannabis medication.
According to the government, this update should be beneficial to those suffering from spastic diseases, and pain issues. Prior to the update, approximately 3,000 approvals for medical cannabis were given yearly to those suffering from the likes of neurological diseases, MS, and cancer.
In order for the amendment to take effect, it required changes to the Narcotics Control Ordinance and the Narcotics List Ordinance. Cultivation regulation for this new medical industry falls under the Swiss Agency for Therapeutic Products (Swissmedic).
Nothing was updated concerning reimbursement for cannabis medications by the healthcare system of the country. As medical cannabis is only reimbursed in the most dire of cases, this indicates that many people will be paying out of pocket for their cannabis medicine, even when legally prescribed by a doctor. The reason given for this omission is that there isn’t enough available evidence on cannabis as an effective treatment, which makes very little sense since it was considered effective enough to be legalized for this purpose.
What about a full recreational legalization?
Switzerland looks like it will be the first country in Europe to set up a regulated sales market, along with trials meant to help establish new regulation. In 2020 I reported about the Swiss government green-lighting trials for recreational cannabis, a project that has been in the works for many years. The trials will allow the legal production and sale of cannabis, but only in specific locations and with many restrictions. In September of 2020, the Federal Act on Narcotics and Psychotropic Substances was officially amended by way of parliamentary approval, which allows scientific trials for selected groups. This went into effect May, 2021.
These regulations set maximum THC limits to 20%, come with limits for pesticide residue, and also mandate warning labels. In order to be a part of these trials, and have access to this recreational cannabis, individual cities and municipalities must first prove that recreational cannabis is not hurting their current population.
As of April 2022, the first of these recreational test programs was authorized specifically for Basel, Switzerland. This specific program is meant to last two years, includes 400 adults, and essentially is meant to provide data for future pricing and consumption regulation, for a full recreational market.
Though the pilot studies sound interesting, they’re really only to help with what’s coming. Even before the programs officially started, a parliamentary commission made a vote in October 2021, which ruled that cannabis shouldn’t be banned, and that the country must establish legislation to officially legalize it. In essence, Switzerland has legalized recreational cannabis, and is simply waiting for a bill (the vote doesn’t change anything without written legislation).
The whole thing is a little confusing. Switzerland is pushing for scientific trials to assess how to run a recreational market, while already working on the legislation to set up that market. And to make it more confusing, the basics of this began before Switzerland even implanted a full medical system, which is only happening now. Somehow none of this seems like its in the right order, but one thing for sure is, progress is great, no matter how it comes. And Switzerland is sure in the fast lane to major cannabis reform.
Perhaps competition with Germany is part of what’s spurring this on so quickly. The neighboring countries are both planning for recreational legalizations, and are both getting amped up to enter the global market. Switzerland for its part is working on both ends. Updating its medical program, before instituting its recreational one.
Welcome all! We appreciate you joining us at Cannadelics.com, a top internet news source for independent coverage of the new and growing cannabis and psychedelics landscapes. Read-thru the site daily for industry updates of all kinds, and check out the Cannadelics Weekly Newsletter, so you always know what’s going down.
- smoking1 year ago
A look inside Jim Belushi's 93-acre cannabis farm in Southern Oregon
- benefits of thcv1 year ago
BREAKING: MASSIVE FOOD SHORTAGE ACROSS THE USA – GOVERNMENT WARNING ON CROP LOSS AND WATER SHORTAGE
- Cannabinoids12 months ago
Legal Loophole? Everyone is Buying Legal Delta 9 THC Gummies Online…
- Deals11 months ago
Have You Tried The New High-Potency THCP Vape Cartridges?
- CBD11 months ago
North Carolina Medical Marijuana Legalization Bill Approved by Senators in Committee
- food1 year ago
Cannabis Infused MCT Oil Tincture FOR HIGH THC EDIBLES
- Cannabinoids1 year ago
What Is HHC (Hexahydrocannabinol) and Is It Safe To Use?
- CBD1 year ago
Federal Cannabis Legalization Will Happen Before 2022, According to Rohrabacher
- Education1 year ago
6 milestones in the CBD industry
- smoking12 months ago
THESE CARDANO PROJECTS WILL 100X IN 2021 🚀 (Get In ASAP)